v3.26.1
Segment Reporting - Summary of Segment Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Abstract]            
CDMO, CRO and other third-party clinical trials and consulting costs $ 7,395   $ 6,915   $ 13,608 $ 11,727
Internal research and development personnel costs 1,496   1,175   2,770 2,244
Other research and development costs 127   350   212 499
General and administrative personnel expenses 1,220   1,094   2,785 1,771
Other general and administrative expenses 2,148   2,722   4,844 6,369
Interest expense 0   0   0 1,443
Other segment items (871)   (906)   (1,848) (2,507)
Net loss $ (11,515) $ (10,856) $ (11,350) $ (10,196) $ (22,371) $ (21,546)